Global Inferior Vena Cava Filters Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Retrievable IVC Filter and Permanent IVC Filter

By Material;

Non-Ferromagnetic Material and Ferromagnetic Materials

By Application;

Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others

By End-Use;

Hospitals, Ambulatory Surgical Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn938488182 Published Date: May, 2025 Updated Date: June, 2025

Inferior Vena Cava Filters Market Overview

Inferior Vena Cava Filters Market (USD Million)

Inferior Vena Cava Filters Market was valued at USD 1,035.40 million in the year 2024. The size of this market is expected to increase to USD 1,941.92 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.4%.


Global Inferior Vena Cava Filters Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 9.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.4 %
Market Size (2024)USD 1,035.40 Million
Market Size (2031)USD 1,941.92 Million
Market ConcentrationMedium
Report Pages306
1,035.40
2024
1,941.92
2031

Major Players

  • Argon Medical Devices, Inc.
  • Lifetech Scientific Co., Ltd.
  • Merit Medical Systems, Inc.
  • Cardinal Health, Inc.
  • Volcano Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Inferior Vena Cava Filters Market

Fragmented - Highly competitive market without dominant players


The inferior vena cava (IVC) filters market is experiencing robust growth, largely driven by the increasing incidence of venous thromboembolism (VTE) and the critical need to prevent pulmonary embolism. With over 30% of hospitalized patients estimated to be at risk for VTE, the demand for preventive solutions such as IVC filters continues to rise. These devices are becoming an integral part of patient care in high-risk clinical settings.

Technological Advancements Driving Adoption
Recent innovations in IVC filter technology have significantly enhanced their performance, leading to greater adoption rates. Improvements such as enhanced retrievability, biocompatible materials, and anti-migration features have contributed to a 20–25% increase in usage over recent years. These advancements have bolstered clinician trust and improved procedural outcomes, fueling market momentum.

Increased Utilization in Surgical and Emergency Settings
The application of IVC filters has expanded into more diverse clinical scenarios, including trauma and perioperative care. Notably, around 18% of trauma patients with contraindications to anticoagulants are now receiving IVC filters, reflecting their rising utility in emergency and surgical settings. This trend highlights the evolving role of these filters beyond conventional therapeutic boundaries.

Regulatory Support and Clinical Guidelines Enhancing Market Clarity
The introduction of updated clinical protocols and safety regulations by health authorities and professional organizations has provided clearer guidance for the use of IVC filters. These refined guidelines promote evidence-based decision-making, reducing complications and fostering responsible use. Such clarity is helping to streamline the adoption process across healthcare facilities.

Rising Focus on Patient Safety and Filter Retrieval
With an increased emphasis on retrievable IVC filters, the industry is shifting towards solutions that prioritize both short-term efficacy and long-term patient safety. Retrieval rates reaching up to 50–60% have underscored the importance of follow-up care and post-placement monitoring. This growing focus is not only driving innovation but also supporting sustained market growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Material
    3. Market Snapshot, By Application
    4. Market Snapshot, By End-use
    5. Market Snapshot, By Region
  4. Inferior Vena Cava Filters Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Venous Thromboembolism (VTE)
        2. Growing Awareness about Pulmonary Embolism (PE) Risks
        3. Advancements in Medical Technology
        4. Rising Geriatric Population
        5. Expansion of Indications for IVC Filter Placement
      2. Restraints
        1. Concerns Regarding Filter Migration and Fracture
        2. Long-term Safety and Efficacy Data
        3. Regulatory Scrutiny and Compliance Challenges
        4. Alternative Treatment Options such as Anticoagulant Therapy
      3. Opportunities
        1. Development of Retrievable and Biodegradable IVC Filters
        2. Expansion into Emerging Markets
        3. Strategic Collaborations and Partnerships
        4. Focus on Patient Education and Awareness
        5. Technological Innovations in Filter Design and Material
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Inferior Vena Cava Filters Market, By Product, 2021 - 2031 (USD Million)
      1. Retrievable IVC Filter
      2. Permanent IVC Filter
    2. Inferior Vena Cava Filters Market, By Material, 2021 - 2031 (USD Million)
      1. Non-Ferromagnetic Material
      2. Ferromagnetic Materials
    3. Inferior Vena Cava Filters Market, By Application, 2021 - 2031 (USD Million)
      1. Treatment Venous Thromboembolism
      2. Prevent Pulmonary Embolism
      3. Others
    4. Inferior Vena Cava Filters Market, By End-use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
    5. Inferior Vena Cava Filters Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN(Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Radcliffe Medical Media
      2. Teleflex Incorporated
      3. Merit Medical Systems, Inc.
      4. Cardinal Health, Inc.
      5. Argon Medical Devices, Inc.
      6. BD
      7. Medtronic
      8. Abbott Laboratories
      9. Terumo Corporation
      10. Johnson & Johnson Services, Inc.
      11. Boston Scientific Corporation
      12. Cordis
      13. C.R. Bard, Inc.
      14. Mermaid Medical
      15. LifeTech Scientific Corporation
      16. Argon Medical Devices
      17. Masimo
      18. B. Braun Interventional Systems Inc.
      19. Braile Biomdica
  7. Analyst Views
  8. Future Outlook of the Market